Endogenous Factors with Immunological and Biological Activity Similar to Cardiac Glycosides: Biochemical and Pathophysiological Implications

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 1992 May 1

PMID 1324267

Authors

A Clerico

G Mariani

Affiliations

Soon will be listed here.

References

Clerico A, Boldrini A, Balzan S, Biver P, Fantoni M . Chromatographic characterization of endogenous digoxin-like immunoreactive substances present in serum and urine of infants using gel filtration with Sephadex G 25. Biol Neonate. 1985; 47(4):217-22. DOI: 10.1159/000242119. View

Alaghband-Zadeh J, Fenton S, Hancock K, Millett J, DE WARDENER H . Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor. J Endocrinol. 1983; 98(2):221-6. DOI: 10.1677/joe.0.0980221. View

Koren G, Farine D, Maresky D, Taylor J, Heyes J, Soldin S . Significance of the endogenous digoxin-like substance in infants and mothers. Clin Pharmacol Ther. 1984; 36(6):759-64. DOI: 10.1038/clpt.1984.254. View

Deray G, Pernollet M, Devynck M, Zingraff J, Touam A, Rosenfeld J . Plasma digitalislike activity in essential hypertension or end-stage renal disease. Hypertension. 1986; 8(7):632-8. DOI: 10.1161/01.hyp.8.7.632. View

Hamlyn J, Blaustein M, Bova S, DUCHARME D, Harris D, Mandel F . Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991; 88(14):6259-63. PMC: 52062. DOI: 10.1073/pnas.88.14.6259. View

Toda N . Mechanisms of ouabain-induced arterial muscle contraction. Am J Physiol. 1980; 239(2):H199-205. DOI: 10.1152/ajpheart.1980.239.2.H199. View

Valdes Jr R, Graves S, Brown B, Landt M . Endogenous substance in newborn infants causing false positive digoxin measurements. J Pediatr. 1983; 102(6):947-50. DOI: 10.1016/s0022-3476(83)80031-6. View

Mir M . Difficulties in the isolation and identification of endogenous ouabain-like substances. Prog Biochem Pharmacol. 1988; 23:1-9. View

Siegfried B, Valdes Jr R . Excretion of endogenous digoxin-like immunoreactive factors in human urine is a function of urine flow rate. Clin Chem. 1988; 34(5):960-4. View

10.

Dorup I, Skajaa K, Clausen T, Kjeldsen K . Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. Br Med J (Clin Res Ed). 1988; 296(6620):455-8. PMC: 2545041. DOI: 10.1136/bmj.296.6620.455. View

11.

Chayen J, Frost G, Dodds R, Bitensky L, Pitchfork J, Baylis P . The use of a hidden metal-capture reagent for the measurement of Na+--K+-ATPase activity: a new concept in cytochemistry. Histochemistry. 1981; 71(4):533-41. DOI: 10.1007/BF00508379. View

12.

BUCKALEW Jr V . Natriuretic hormone: current status. Am J Nephrol. 1989; 9(4):329-42. DOI: 10.1159/000167989. View

13.

Pudek M, Seccombe D, Jacobson B, Whitfield M . Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clin Chem. 1983; 29(11):1972-4. View

14.

Feldt-Rasmussen B, Mathiesen E, Deckert T, Giese J, Christensen N, Nielsen M . Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987; 30(8):610-7. DOI: 10.1007/BF00277316. View

15.

Doris P, Stocco D . An endogenous digitalis-like factor derived from the adrenal gland: studies of adrenal tissue from various sources. Endocrinology. 1989; 125(5):2573-9. DOI: 10.1210/endo-125-5-2573. View

16.

Lau B, Valdes Jr R . Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans. Clin Chim Acta. 1988; 175(1):67-77. DOI: 10.1016/0009-8981(88)90036-8. View

17.

Blaustein M, Hamlyn J . Role of a natriuretic factor in essential hypertension: an hypothesis. Ann Intern Med. 1983; 98(5 Pt 2):785-92. DOI: 10.7326/0003-4819-98-5-785. View

18.

Hamlyn J, Harris D, Clark M, Rogowski A, White R, Ludens J . Isolation and characterization of a sodium pump inhibitor from human plasma. Hypertension. 1989; 13(6 Pt 2):681-9. DOI: 10.1161/01.hyp.13.6.681. View

19.

Blaustein M, Ashida T, Goldman W, Wier W, Hamlyn J . Sodium/calcium exchange in vascular smooth muscle: a link between sodium metabolism and hypertension. Ann N Y Acad Sci. 1986; 488:199-216. DOI: 10.1111/j.1749-6632.1986.tb46559.x. View

20.

Ford A, Aronson J, Grahame-Smith D, Carver J . The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological.... Br J Clin Pharmacol. 1979; 8(2):135-42. PMC: 1429774. DOI: 10.1111/j.1365-2125.1979.tb05811.x. View